Request Your Free White Paper Now:

"Enhancing Gene Therapy Manufacturing Through Advanced Viral Vector Purification Technologies"

Download this free whitepaper to learn more

As gene therapy programs scale, downstream processing remains a critical bottleneck. Manual density gradient ultracentrifugation is time-consuming, variable and difficult to scale — limiting throughput and increasing risk in regulated environments.

This white paper explores how a semi-automated purification workflow using the OptiMATE™ Gradient Maker and Optima™ X-Series Ultracentrifuges helps manufacturers reduce variability, shorten run times and achieve consistent, high-resolution separation of full and empty AAV capsids.

What You’ll Learn

• Why downstream processing is the biggest challenge in AAV manufacturing
• How pre-formed gradients can cut ultracentrifuge run times by more than 75%
• Real-world performance data and case study results
• How standardized workflows support scalability and GMP compliance

Download the white paper to learn how advanced purification technologies are redefining efficiency and precision in gene therapy manufacturing.

Offered Free by: Beckman Coulter Life Sciences
See All Resources from: Beckman Coulter Life Sciences